Search Results - Per Odin

Refine Results
  1. 1

    Compliance with National and International Guidelines in the Treatment of Nonmotor Symptoms in Late-Stage Parkinson’s Disease by Kristina Rosqvist, Per Odin

    Published in Parkinson's Disease (2023-01-01)
    Get full text
    Article


  2. 2

    Effects of rotigotine on sleep in Parkinson’s disease patients: a Parkinson’s KinetiGraph study by Sotirios Grigoriou, Sotirios Grigoriou, Carin Janz, Carin Janz, Malcolm Horne, Filip Bergquist, Filip Bergquist, Nil Dizdar, Per Odin, Per Odin

    Published in Frontiers in Neurology (2025-05-01)
    Get full text
    Article


  3. 3

    Caregiver Burden and Quality of Life in Late Stage Parkinson’s Disease by Kristina Rosqvist, Anette Schrag, Per Odin, the CLaSP Consortium

    Published in Brain Sciences (2022-01-01)
    Get full text
    Article


  4. 4

    Time to workforce exit after a Parkinson’s disease diagnosis by Jonathan Timpka, Örjan Dahlström, Maria H. Nilsson, Susanne Iwarsson, Per Odin

    Published in npj Parkinson's Disease (2023-05-01)
    Get full text
    Article


  5. 5

    Tumoral parkinsonism—Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treat... by Gustav Cedergren Weber, Jonathan Timpka, Anna Rydelius, Johan Bengzon, Per Odin

    Published in Brain and Behavior (2023-08-01)
    Get full text
    Article


  6. 6

    Satisfaction with Care in Late Stage Parkinson’s Disease by Kristina Rosqvist, Peter Hagell, Susanne Iwarsson, Maria H Nilsson, Per Odin

    Published in Parkinson's Disease (2019-01-01)
    Get full text
    Article


  7. 7

    Perspectives on Care for Late-Stage Parkinson’s Disease by Kristina Rosqvist, Marianne Kylberg, Charlotte Löfqvist, Anette Schrag, Per Odin, Susanne Iwarsson

    Published in Parkinson's Disease (2021-01-01)
    Get full text
    Article


  8. 8

    Personality Trait Changes After Device-Aided Therapy: Insights From Parkinson’s Patients and Their Close Relatives by Monica Scharfenort, Veronica Hernström, Kristina Rosqvist, Hanna Ljung, Maria H. Nilsson, Per Odin

    Published in Parkinson's Disease (2025-01-01)
    Get full text
    Article


  9. 9

    Validation of the PD home diary for assessment of motor fluctuations in advanced Parkinson’s disease by Matthias Löhle, Alexander Bremer, Florin Gandor, Jonathan Timpka, Per Odin, Georg Ebersbach, Alexander Storch

    Published in npj Parkinson's Disease (2022-06-01)
    Get full text
    Article


  10. 10

    Correction: Levodopa Intestinal Gel Infusion Therapies in Advanced Parkinson’s Disease: A Swedish Study on Real-World Use and Costs by Per Odin, Christoffer Tærud, Jenny Samuelsson, Emma Sabelström, Jeanette Lagerlund, Jonatan Freilich, M. Natalia Stelmaszuk

    Published in Neurology and Therapy (2025-07-01)
    Get full text
    Article


  11. 11

    Levodopa Intestinal Gel Infusion Therapies in Advanced Parkinson’s Disease: A Swedish Study on Real-World Use and Costs by Per Odin, Christoffer Tærud, Jenny Samuelsson, Emma Sabelström, Jeanette Lagerlund, Jonatan Freilich, M. Natalia Stelmaszuk

    Published in Neurology and Therapy (2025-06-01)
    Get full text
    Article


  12. 12

    Platelet-Derived Growth Factor Receptor Expression after Neural Grafting in a Rat Model of Parkinson's Disease by Andrea E. Ballagi, Per Odin, Agneta Othberg-Cederström, Anja Smits, Wei-Ming Duandr, Olle Lindvall, Keiko Funa

    Published in Cell Transplantation (1994-11-01)
    Get full text
    Article


  13. 13

    Application of single wrist-wearable accelerometry for objective motor diary assessment in fluctuating Parkinson’s disease by Matthias Löhle, Jonathan Timpka, Alexander Bremer, Hamid Khodakarami, Florin Gandor, Malcom Horne, Georg Ebersbach, Per Odin, Alexander Storch

    Published in npj Digital Medicine (2023-10-01)
    Get full text
    Article


  14. 14

    Safinamide in the treatment pathway of Parkinson’s Disease: a European Delphi Consensus by Fabrizio Stocchi, Angelo Antonini, Daniela Berg, Bruno Bergmans, Wolfgang Jost, Regina Katzenschlager, Jaime Kulisevsky, Per Odin, Francesc Valldeoriola, K. Ray Chaudhuri

    Published in npj Parkinson's Disease (2022-02-01)
    Get full text
    Article


  15. 15

    Study protocol: Care of Late-Stage Parkinsonism (CLaSP): a longitudinal cohort study by Monika Balzer-Geldsetzer, Joaquim Ferreira, Per Odin, Bastiaan R. Bloem, Wassilios G. Meissner, Stefan Lorenzl, Michael Wittenberg, Richard Dodel, Anette Schrag

    Published in BMC Neurology (2018-11-01)
    Get full text
    Article


  16. 16

    Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease? by Silvia Rota, Daniele Urso, Daniel J. van Wamelen, Valentina Leta, Iro Boura, Per Odin, Alberto J. Espay, Peter Jenner, K. Ray Chaudhuri

    Published in Translational Neurodegeneration (2022-10-01)
    Get full text
    Article


  17. 17

    Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease by Per Odin, K. Ray Chaudhuri, Jens Volkmann, Angelo Antonini, Alexander Storch, Espen Dietrichs, Zvezdan Pirtošek, Tove Henriksen, Malcolm Horne, David Devos, Filip Bergquist

    Published in npj Parkinson's Disease (2018-05-01)
    Get full text
    Article


  18. 18

    A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need. by Kallol Ray Chaudhuri, Jose Manuel Rojo, Anthony H V Schapira, David J Brooks, Fabrizio Stocchi, Per Odin, Angelo Antonini, Richard G Brown, Pablo Martinez-Martin

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  19. 19

    The Possible Clinical Predictors of Fatigue in Parkinson’s Disease: A Study of 135 Patients as Part of International Nonmotor Scale Validation Project by Vinod Metta, Kartik Logishetty, P. Martinez-Martin, Heather M. Gage, P. E. S. Schartau, T. K. Kaluarachchi, Anne Martin, Per Odin, P. Barone, Fabrizio Stocchi, A. Antonini, K. Ray Chaudhuri

    Published in Parkinson's Disease (2011-01-01)
    Get full text
    Article


  20. 20

    Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind O... by K. Ray Chaudhuri, Per Odin, Joaquim J. Ferreira, Angelo Antonini, Olivier Rascol, Mónica M. Kurtis, Alexander Storch, Kirsty Bannister, Patrício Soares-da-Silva, Raquel Costa, Diogo Magalhães, José Francisco Rocha

    Published in BMC Neurology (2022-03-01)
    Get full text
    Article


Search Tools: